Literature DB >> 25647237

Respiratory Dysfunction Associated With RBC Transfusion in Critically Ill Children: A Prospective Cohort Study.

Niina Kleiber1, Émilie Lefebvre, France Gauvin, Marisa Tucci, Nancy Robitaille, Helen Trottier, Philippe Jouvet, Thierry Ducruet, Nicole Poitras, Jacques Lacroix, Guillaume Emeriaud.   

Abstract

OBJECTIVE: Respiratory complications associated with RBC transfusions may be underestimated in PICUs because current definitions exclude patients with preexisting respiratory dysfunction. This study aims to determine the prevalence and characterize the risk factors and outcomes of new or progressive respiratory dysfunction observed after RBC transfusion in critically ill children.
DESIGN: Prospective cohort study of all children admitted over a 1-year period.
SETTING: A multidisciplinary PICU in a tertiary pediatric university hospital. PATIENTS: Patients who received a RBC transfusion while in PICU.
INTERVENTIONS: None.
MEASUREMENTS AND MAIN RESULTS: Two independent adjudicators established the diagnosis of respiratory dysfunction. A respiratory dysfunction associated with transfusion was considered new if it appeared after the first RBC transfusion in PICU. A progressive respiratory dysfunction associated with transfusion was diagnosed if the respiratory dysfunction was present before the transfusion and the PaO2/FIO2 or the SpO2/FIO2 ratio dropped by at least 20% thereafter. Among 842 children admitted into the PICU, 136 received at least one RBC transfusion and were analyzed. Fifty-eight cases of respiratory dysfunction associated with transfusion (43% of transfused patients) were detected, including nine new respiratory dysfunction associated with transfusion (7%) and 49 progressive respiratory dysfunction associated with transfusion (36%). Higher severity of illness, multiple organ dysfunction syndrome prior to transfusion, and volume (mL/kg) of RBC transfusion were independently associated with respiratory dysfunction associated with transfusion. A dose-response relationship was observed between transfusion volume (mL/kg) and the prevalence of respiratory dysfunction associated with transfusion. Patients with respiratory dysfunction associated with transfusion had more progressive multiple organ dysfunction and less ventilation-free and PICU-free days at day 28.
CONCLUSIONS: Development of respiratory dysfunction associated with transfusion is frequent in PICU and occurs mainly in patients with prior respiratory dysfunction, who would not be identified using current definitions for transfusion-associated complications. A cause-effect relationship cannot be confirmed. However, the high prevalence and the serious adverse outcomes associated with respiratory dysfunction associated with transfusion suggest that this complication should be further studied.

Entities:  

Mesh:

Year:  2015        PMID: 25647237     DOI: 10.1097/PCC.0000000000000365

Source DB:  PubMed          Journal:  Pediatr Crit Care Med        ISSN: 1529-7535            Impact factor:   3.624


  11 in total

1.  Neonatal outcome of small for gestational age preterm infants.

Authors:  Stefano Nobile; Paolo Marchionni; Virgilio P Carnielli
Journal:  Eur J Pediatr       Date:  2017-06-28       Impact factor: 3.183

Review 2.  Transfusion in children with acute respiratory distress syndrome.

Authors:  Tine François; Guillaume Emeriaud; Oliver Karam; Marisa Tucci
Journal:  Ann Transl Med       Date:  2019-10

3.  RBC Transfusions Are Associated With Prolonged Mechanical Ventilation in Pediatric Acute Respiratory Distress Syndrome.

Authors:  Michael E Zubrow; Neal J Thomas; David F Friedman; Nadir Yehya
Journal:  Pediatr Crit Care Med       Date:  2018-02       Impact factor: 3.624

4.  Recommendations on RBC Transfusion in General Critically Ill Children Based on Hemoglobin and/or Physiologic Thresholds From the Pediatric Critical Care Transfusion and Anemia Expertise Initiative.

Authors:  Allan Doctor; Jill M Cholette; Kenneth E Remy; Andrew Argent; Jeffrey L Carson; Stacey L Valentine; Scot T Bateman; Jacques Lacroix
Journal:  Pediatr Crit Care Med       Date:  2018-09       Impact factor: 3.624

5.  Recommendations on RBC Transfusions in Critically Ill Children With Acute Respiratory Failure From the Pediatric Critical Care Transfusion and Anemia Expertise Initiative.

Authors:  Pierre Demaret; Guillaume Emeriaud; Nabil E Hassan; Martin C J Kneyber; Stacey L Valentine; Scot T Bateman; Marisa Tucci
Journal:  Pediatr Crit Care Med       Date:  2018-09       Impact factor: 3.624

6.  RBC Transfusion Practice in Pediatric Extracorporeal Membrane Oxygenation Support.

Authors:  Jennifer A Muszynski; Ron W Reeder; Mark W Hall; Robert A Berg; Thomas P Shanley; Christopher J L Newth; Murray M Pollack; David Wessel; Joseph Carcillo; Rick Harrison; Kathleen L Meert; J Michael Dean; Tammara Jenkins; Robert F Tamburro; Heidi J Dalton
Journal:  Crit Care Med       Date:  2018-06       Impact factor: 7.598

7.  Factors Associated with Bleeding and Thrombosis in Children Receiving Extracorporeal Membrane Oxygenation.

Authors:  Heidi J Dalton; Ron Reeder; Pamela Garcia-Filion; Richard Holubkov; Robert A Berg; Athena Zuppa; Frank W Moler; Thomas Shanley; Murray M Pollack; Christopher Newth; John Berger; David Wessel; Joseph Carcillo; Michael Bell; Sabrina Heidemann; Kathleen L Meert; Richard Harrison; Allan Doctor; Robert F Tamburro; J Michael Dean; Tammara Jenkins; Carol Nicholson
Journal:  Am J Respir Crit Care Med       Date:  2017-09-15       Impact factor: 21.405

8.  Hemolysis During Pediatric Extracorporeal Membrane Oxygenation: Associations With Circuitry, Complications, and Mortality.

Authors:  Heidi J Dalton; Katherine Cashen; Ron W Reeder; Robert A Berg; Thomas P Shanley; Christopher J L Newth; Murray M Pollack; David Wessel; Joseph Carcillo; Rick Harrison; J Michael Dean; Kathleen L Meert
Journal:  Pediatr Crit Care Med       Date:  2018-11       Impact factor: 3.624

Review 9.  Transfusion-related immunomodulation: review of the literature and implications for pediatric critical illness.

Authors:  Jennifer A Muszynski; Philip C Spinella; Jill M Cholette; Jason P Acker; Mark W Hall; Nicole P Juffermans; Daniel P Kelly; Neil Blumberg; Kathleen Nicol; Jennifer Liedel; Allan Doctor; Kenneth E Remy; Marisa Tucci; Jacques Lacroix; Philip J Norris
Journal:  Transfusion       Date:  2016-10-02       Impact factor: 3.157

10.  Multiple organ dysfunction syndrome in critically ill children: clinical value of two lists of diagnostic criteria.

Authors:  Andréanne Villeneuve; Jean-Sébastien Joyal; François Proulx; Thierry Ducruet; Nicole Poitras; Jacques Lacroix
Journal:  Ann Intensive Care       Date:  2016-04-29       Impact factor: 6.925

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.